Drug Name |
PF-4989216
|
Synonyms |
PI3K inhibitor (cancer), Pfizer |
Indication |
Disease Entry |
ICD 11 |
Status |
REF |
Solid tumour/cancer |
2A00-2F9Z
|
Investigative |
[1] |
------------------------------------------------------------------------------------ |
|
|
|
|
Structure |
|
|
3D MOL
|
2D MOL
|
#Ro5 Violations (Lipinski): 0 |
Molecular Weight (mw) |
380.4 |
|
Logarithm of the Partition Coefficient (xlogp) |
2.6 |
Rotatable Bond Count (rotbonds) |
3 |
Hydrogen Bond Donor Count (hbonddonor) |
1 |
Hydrogen Bond Acceptor Count (hbondacc) |
8 |
Chemical Identifiers |
- Formula
- C18H13FN6OS
- IUPAC Name
4-(4-cyano-2-fluorophenyl)-2-morpholin-4-yl-5-(1H-1,2,4-triazol-5-yl)thiophene-3-carbonitrile
- Canonical SMILES
-
C1COCCN1C2=C(C(=C(S2)C3=NC=NN3)C4=C(C=C(C=C4)C#N)F)C#N
- InChI
-
InChI=1S/C18H13FN6OS/c19-14-7-11(8-20)1-2-12(14)15-13(9-21)18(25-3-5-26-6-4-25)27-16(15)17-22-10-23-24-17/h1-2,7,10H,3-6H2,(H,22,23,24)
- InChIKey
-
MUENOTXSRZEFJV-UHFFFAOYSA-N
|
Cross-matching ID |
- PubChem CID
- 51033720
- TTD ID
- D00JIV
|
Combinatorial Drugs (CBD) |
Click to Jump to the Detailed CBD Information of This Drug
|
|
|
|
|
|
|
|